Year: 2016
Type: article
Abstract: In view of the growing trend in personalizing medicine and with the development of sophisticated equipment and algorithms for guiding radiotherapies, more precise doses and/or particle beams can be delivered to the target tumor while minimizing side effects to the surrounding healthy tissue, which opened up access to new delivery modalities and clinical protocols.Although many clinical studies are trying to evaluate the differential effects between different types of radiotherapy on patients' outcomes, the biological response at the cellular level, and the different cellular pathways involved, are yet inadequately be explored.Novel technologies to evaluate genomics or proteomics-based effects in tumor tissue, but also in bodily fluids, have revealed molecular information that will open the doors for new clinical understanding in Oncology.This lecture will discuss these omics applications in the context of the most recent technologies.
Source: Radiotherapy and Oncology
Author: F. Zenhausern
Institution: University of Arizona
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,770
OpenAlex ID: W2320405630